US6969601B2
(en)
|
1997-04-03 |
2005-11-29 |
Jensenius Jens Chr |
MASP-2, a complement-fixing enzyme, and uses for it
|
CN1854157B
(zh)
*
|
2001-01-05 |
2013-01-02 |
辉瑞大药厂 |
胰岛素样生长因子i受体的抗体
|
US20080152649A1
(en)
*
|
2002-03-01 |
2008-06-26 |
Xencor, Inc. |
Optimized igf-1r antibodies and methods of using the same
|
NZ571508A
(en)
*
|
2002-05-24 |
2010-05-28 |
Schering Corp |
Neutralizing human anti-IGFR antibody
|
US8034904B2
(en)
*
|
2002-06-14 |
2011-10-11 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
US7538195B2
(en)
|
2002-06-14 |
2009-05-26 |
Immunogen Inc. |
Anti-IGF-I receptor antibody
|
US20060002935A1
(en)
*
|
2002-06-28 |
2006-01-05 |
Domantis Limited |
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
|
US7541440B2
(en)
*
|
2002-09-30 |
2009-06-02 |
Immunomedics, Inc. |
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
|
US7919083B2
(en)
*
|
2002-11-15 |
2011-04-05 |
Morehouse School Of Medicine |
Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
|
US7132111B2
(en)
*
|
2003-01-03 |
2006-11-07 |
Epien Medical, Inc. |
Odorless formulation for treating mucosal discontinuities
|
ES2527871T3
(es)
*
|
2003-05-01 |
2015-02-02 |
Imclone Llc |
Anticuerpos completamente humanos dirigidos contra el receptor del factor de crecimiento 1 similar a la insulina humana
|
HUE024996T2
(en)
|
2003-05-12 |
2016-01-28 |
Helion Biotech Aps |
Anti-MASP-2 antibodies
|
AR046071A1
(es)
*
|
2003-07-10 |
2005-11-23 |
Hoffmann La Roche |
Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
|
DE602004029581D1
(de)
*
|
2003-08-13 |
2010-11-25 |
Pfizer Prod Inc |
Modifizierte humane igf-1r antikörper
|
US7326567B2
(en)
|
2003-11-12 |
2008-02-05 |
Schering Corporation |
Plasmid system for multigene expression
|
AR046639A1
(es)
*
|
2003-11-21 |
2005-12-14 |
Schering Corp |
Combinaciones terapeuticas de anticuerpo anti- igfr1
|
CA2548065A1
(en)
*
|
2003-12-08 |
2005-07-07 |
Immunogen, Inc. |
Anti-igf-i receptor antibody
|
JP5137053B2
(ja)
*
|
2004-02-10 |
2013-02-06 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイト |
抗b因子抗体もしくはその抗原結合性フラグメント、それを含む組成物、抗原結合性ポリペプチド、および治療薬
|
JP5128935B2
(ja)
*
|
2004-03-31 |
2013-01-23 |
ジェネンテック, インコーポレイテッド |
ヒト化抗TGF−β抗体
|
BRPI0510883B8
(pt)
*
|
2004-06-01 |
2021-05-25 |
Genentech Inc |
composto conjugado de droga e anticorpo, composição farmacêutica, método de fabricação de composto conjugado de droga e anticorpo e usos de uma formulação, de um conjugado de droga e anticorpo e um agente quimioterapêutico e de uma combinação
|
US7919094B2
(en)
*
|
2004-06-10 |
2011-04-05 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
US8840893B2
(en)
|
2004-06-10 |
2014-09-23 |
Omeros Corporation |
Methods for treating conditions associated with MASP-2 dependent complement activation
|
NZ552091A
(en)
*
|
2004-07-16 |
2009-09-25 |
Pfizer Prod Inc |
Combination treatment for non-hematologic malignancies using an anti-IGF-1R antibody
|
FR2873699B1
(fr)
|
2004-07-29 |
2009-08-21 |
Pierre Fabre Medicament Sa |
Nouveaux anticorps anti igf ir rt leurs utilisations
|
AU2011236042B2
(en)
*
|
2004-07-29 |
2013-09-05 |
Pierre Fabre Medicament |
Novel anti-IGF-IR antibodies and uses thereof
|
US20060134098A1
(en)
*
|
2004-11-16 |
2006-06-22 |
Kalobios, Inc. |
Immunoglobulin variable region cassette exchange
|
WO2006060419A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Schering Corporation |
Biomarkers for pre-selection of patients for anti-igf1r therapy
|
MY146381A
(en)
*
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
US7524831B2
(en)
*
|
2005-03-02 |
2009-04-28 |
Schering Corporation |
Treatments for Flaviviridae virus infection
|
BRPI0608777A2
(pt)
*
|
2005-04-15 |
2010-01-26 |
Schering Corp |
métodos para tratamento ou prevenção de cáncer, bem como uso de inibidores de igf1r na preparação de composições farmacêuticas
|
JP5129122B2
(ja)
|
2005-04-26 |
2013-01-23 |
トリオン ファーマ ゲーエムベーハー |
癌治療のための抗体およびグルココルチコイドの組み合わせ
|
AU2006249835B2
(en)
*
|
2005-05-26 |
2011-09-08 |
Musc Foundation For Research Development |
Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions
|
AU2006259536A1
(en)
*
|
2005-06-15 |
2006-12-28 |
Schering Corporation |
Anti-IGF1R antibody formulations
|
JP2009501141A
(ja)
*
|
2005-06-17 |
2009-01-15 |
イムクローン システムズ インコーポレイテッド |
転移性骨癌の治療のための受容体アンタゴニスト
|
WO2007000328A1
(en)
*
|
2005-06-27 |
2007-01-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Antibodies that bind to an epitope on insulin-like growth factor 1 receptor and uses thereof
|
FR2888850B1
(fr)
|
2005-07-22 |
2013-01-11 |
Pf Medicament |
Nouveaux anticorps anti-igf-ir et leurs applications
|
JP5198289B2
(ja)
|
2006-02-03 |
2013-05-15 |
イムクローン・リミテッド・ライアビリティ・カンパニー |
前立腺癌の治療用アジュバントとしてのigf−irアンタゴニスト
|
WO2007093008A1
(en)
*
|
2006-02-17 |
2007-08-23 |
Adelaide Research & Innovation Pty Ltd |
Antibodies to insulin-like growth factor i receptor
|
US7846724B2
(en)
|
2006-04-11 |
2010-12-07 |
Hoffmann-La Roche Inc. |
Method for selecting CHO cell for production of glycosylated antibodies
|
EP3018142A1
(de)
*
|
2006-06-06 |
2016-05-11 |
Crucell Holland B.V. |
Menschliche bindende molekule mit abtotungswirkung gegen staphylokokken und ihre verwendung
|
ES2427924T3
(es)
|
2006-06-30 |
2013-11-04 |
Merck Sharp & Dohme Corp. |
Biomarcador IGFBP2
|
NZ574215A
(en)
*
|
2006-07-18 |
2012-07-27 |
Sanofi Aventis |
Antagonist antibody against epha2 for the treatment of cancer
|
EP1914242A1
(de)
|
2006-10-19 |
2008-04-23 |
Sanofi-Aventis |
Neue Antikörper gegen CD38 zur Behandlung von Krebs
|
AU2007334456A1
(en)
|
2006-12-13 |
2008-06-26 |
Merck Sharp & Dohme Corp. |
Methods of cancer treatment with IGF1R inhibitors
|
AR064464A1
(es)
*
|
2006-12-22 |
2009-04-01 |
Genentech Inc |
Anticuerpos anti - receptor del factor de crecimiento insulinico
|
GB0702888D0
(en)
*
|
2007-02-14 |
2007-03-28 |
Glaxo Group Ltd |
Novel Antibodies
|
MX2009008754A
(es)
*
|
2007-02-14 |
2009-11-02 |
Glaxo Group Ltd |
Anticuerpos novedosos contra igf-1r.
|
ES2707551T3
(es)
*
|
2007-03-02 |
2019-04-04 |
Amgen Inc |
Métodos y composiciones para tratar enfermedades tumorales
|
AU2008251943B2
(en)
|
2007-03-14 |
2013-09-05 |
Alexion Pharmaceuticals, Inc. |
Humaneered anti-factor B antibody
|
WO2008144345A2
(en)
|
2007-05-17 |
2008-11-27 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to insulin growth factor-1 receptor modulators
|
PE20090368A1
(es)
|
2007-06-19 |
2009-04-28 |
Boehringer Ingelheim Int |
Anticuerpos anti-igf
|
WO2009029795A1
(en)
*
|
2007-08-31 |
2009-03-05 |
Amgen Inc. |
Solid-state protein formulation
|
CA2701032C
(en)
|
2007-09-27 |
2021-01-26 |
Amgen Inc. |
Pharmaceutical formulations
|
WO2009064838A1
(en)
|
2007-11-15 |
2009-05-22 |
Amgen, Inc. |
Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration
|
CA2709029A1
(en)
|
2007-12-21 |
2009-07-02 |
Bianca Eser |
Stability testing of antibodies
|
TWI675668B
(zh)
|
2008-03-18 |
2019-11-01 |
美商建南德克公司 |
抗her2抗體-藥物結合物及化療劑之組合及使用方法
|
KR101687032B1
(ko)
|
2008-05-07 |
2016-12-15 |
아고스 쎄라퓨틱스, 인코포레이티드 |
인간 인터페론-알파에 대한 인간화 항체
|
PE20120415A1
(es)
|
2008-12-12 |
2012-05-09 |
Boehringer Ingelheim Int |
Anticuerpos anti-igf
|
AU2010210646B2
(en)
|
2009-02-05 |
2015-10-29 |
Immunogen, Inc. |
Novel benzodiazepine derivatives
|
CN102481361B
(zh)
|
2009-04-16 |
2014-10-22 |
默沙东公司 |
用于治疗癌症的组合物和方法
|
WO2010146059A2
(en)
|
2009-06-16 |
2010-12-23 |
F. Hoffmann-La Roche Ag |
Biomarkers for igf-1r inhibitor therapy
|
RS20120461A1
(en)
|
2009-07-02 |
2013-06-28 |
Musc Foundation For Research Development |
METHODS FOR STIMULATION OF LIVER REGENERATION
|
CA2971474C
(en)
*
|
2009-10-16 |
2022-11-22 |
Omeros Corporation |
Methods for treating disseminated intravascular coagulation by inhibiting masp-2 dependent complement activation
|
US9662271B2
(en)
|
2009-10-23 |
2017-05-30 |
Amgen Inc. |
Vial adapter and system
|
AU2010311567B2
(en)
|
2009-10-26 |
2015-03-26 |
Chugai Seiyaku Kabushiki Kaisha |
Method for the production of a glycosylated immunoglobulin
|
EP2494070A2
(de)
|
2009-10-30 |
2012-09-05 |
Bristol-Myers Squibb Company |
Verfahren zur krebsbehandlung bei patienten mit igf-1r-hemmer-resistenz
|
MX341687B
(es)
|
2010-02-10 |
2016-08-30 |
Immunogen Inc |
"anticuerpos cd20 y su utilización".
|
WO2011101328A2
(en)
|
2010-02-18 |
2011-08-25 |
Roche Glycart Ag |
Treatment with a humanized igg class anti egfr antibody and an antibody against insulin like growth factor 1 receptor
|
NZ724971A
(en)
|
2010-02-24 |
2019-06-28 |
Immunogen Inc |
Folate receptor 1 antibodies and immunoconjugates and uses thereof
|
EP2575935B2
(de)
|
2010-06-07 |
2023-08-23 |
Amgen Inc. |
Wirkstofffreisetzungsvorrichtung
|
WO2011161119A1
(en)
|
2010-06-22 |
2011-12-29 |
F. Hoffmann-La Roche Ag |
Antibodies against insulin-like growth factor i receptor and uses thereof
|
EP2670426B1
(de)
|
2011-01-31 |
2017-05-10 |
The General Hospital Corporation |
Multimodale trail-moleküle und ihre verwendungen in zelltherapien
|
US20140037642A1
(en)
|
2011-02-02 |
2014-02-06 |
Amgen Inc. |
Methods and compositions relating to inhibition of igf-1r
|
SI2675479T1
(sl)
*
|
2011-02-15 |
2016-04-29 |
Immunogen, Inc. |
Citotoksični derivati benzodiazepina
|
CA2831100C
(en)
|
2011-03-31 |
2020-02-18 |
Mark Dominis Holt |
Vial adapter and system
|
CA3021845C
(en)
|
2011-04-20 |
2022-03-29 |
Amgen Inc. |
Autoinjector apparatus
|
EP2766497A1
(de)
|
2011-10-13 |
2014-08-20 |
Bristol-Myers Squibb Company |
Verfahren zur auswahl und behandlung von krebs bei patienten mit igf-1r/ir-hemmern
|
IL301153B2
(en)
|
2011-10-14 |
2024-05-01 |
Amgen Inc |
Syringe and assembly method
|
US9700619B2
(en)
|
2011-11-11 |
2017-07-11 |
Duke University |
Combination drug therapy for the treatment of solid tumors
|
CN104093743B
(zh)
|
2011-11-23 |
2018-04-24 |
医学免疫有限责任公司 |
特异于her3的结合分子及其用途
|
EP2855529A4
(de)
|
2012-05-24 |
2015-12-09 |
Alexion Pharma Inc |
Humanisierte anti-faktor-b-antikörper
|
US8980259B2
(en)
|
2012-07-20 |
2015-03-17 |
Novartis Ag |
Combination therapy
|
US9862932B2
(en)
|
2012-07-24 |
2018-01-09 |
The General Hospital Corporation |
Oncolytic virus therapy for resistant tumors
|
WO2014035474A1
(en)
*
|
2012-08-30 |
2014-03-06 |
The General Hospital Corporation |
Compositions and methods for treating cancer
|
PL2890717T3
(pl)
|
2012-08-31 |
2020-08-10 |
Immunogen, Inc. |
Testy i zestawy diagnostyczne do wykrywania receptora folianu
|
EP2727941A1
(de)
|
2012-11-05 |
2014-05-07 |
MAB Discovery GmbH |
Verfahren zur Herstellung multispezifischer Antikörper
|
US20150259430A1
(en)
|
2012-11-05 |
2015-09-17 |
Mab Discovery Gmbh |
Method for the production of multispecific antibodies
|
EP4234694A3
(de)
|
2012-11-21 |
2023-09-06 |
Amgen Inc. |
Arzneimittelabgabevorrichtung
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
US20140255413A1
(en)
|
2013-03-07 |
2014-09-11 |
Boehringer Ingelheim International Gmbh |
Combination therapy for neoplasia treatment
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
TWI580452B
(zh)
|
2013-03-15 |
2017-05-01 |
安美基公司 |
用於注射器之匣盒、注射器及使用包括自動注射器及匣盒之設備之方法
|
CN105377327B
(zh)
|
2013-03-22 |
2021-06-22 |
安姆根有限公司 |
注射器及装配方法
|
CN112142845A
(zh)
*
|
2013-08-13 |
2020-12-29 |
赛诺菲 |
纤溶酶原激活剂抑制剂-1(pai-1)的抗体及其用途
|
CN105744944B
(zh)
|
2013-09-09 |
2020-07-07 |
卡尼姆盖德治疗学公司 |
免疫系统调节器
|
SG11201602876WA
(en)
|
2013-10-24 |
2016-05-30 |
Amgen Inc |
Injector and method of assembly
|
EP3060281B1
(de)
|
2013-10-24 |
2019-01-30 |
Amgen Inc. |
Arzneimittelabgabesystem mit temperaturempfindlicher steuerung
|
KR20160127736A
(ko)
*
|
2014-01-24 |
2016-11-04 |
더 헨리 엠. 잭슨 파운데이션 포 더 어드벤스먼트 오브 밀리터리 메디신, 인코포레이티드 |
헨드라 및 니파 바이러스의 f 당단백질에 대한 항체
|
WO2015119906A1
(en)
|
2014-02-05 |
2015-08-13 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
WO2015157238A2
(en)
|
2014-04-08 |
2015-10-15 |
Medimmune, Llc |
Binding molecules specific for il-21 and uses thereof
|
US10160812B2
(en)
|
2014-04-11 |
2018-12-25 |
Medimmune, Llc |
Bispecific HER2 antibodies
|
US10722655B2
(en)
|
2014-05-07 |
2020-07-28 |
Amgen Inc. |
Autoinjector with shock reducing elements
|
CN106470716B
(zh)
|
2014-06-03 |
2020-07-17 |
安姆根有限公司 |
可控制药物递送系统和使用方法
|
CA2957960C
(en)
|
2014-10-14 |
2023-08-22 |
Amgen, Inc. |
Drug injection device with visual and audible indicators
|
BR112017009398A2
(pt)
|
2014-11-10 |
2018-05-15 |
Medimmune Ltd |
moléculas de ligação específicas para cd73 e seus usos
|
GB2538120A
(en)
|
2014-11-11 |
2016-11-09 |
Medimmune Ltd |
Therapeutic combinations comprising anti-CD73 antibodies and uses thereof
|
ES2898469T3
(es)
|
2014-12-19 |
2022-03-07 |
Amgen Inc |
Dispositivo de administración de medicamentos con sensor de proximidad
|
EP3233159B1
(de)
|
2014-12-19 |
2020-03-04 |
Amgen Inc. |
Medikamentenabgabevorrichtung mit beweglicher taste oder bedienfeld
|
JP6484345B2
(ja)
|
2015-02-17 |
2019-03-20 |
アムジエン・インコーポレーテツド |
固定及び/または戻りが真空によって支援された薬物送達装置
|
US11806509B2
(en)
|
2015-02-27 |
2023-11-07 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a turnable threshold of resistance to needle guard movement
|
DK3265117T3
(da)
|
2015-03-06 |
2021-02-08 |
Canimguide Therapeutics Ab |
Immunsystemmodulatorer og præparater
|
BR112017027254A2
(pt)
|
2015-06-29 |
2019-05-14 |
Immunogen, Inc. |
anticorpos anti-cd123 e conjugados e derivados dos mesmos
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
PL3374398T3
(pl)
|
2015-11-10 |
2020-08-24 |
Medimmune, Llc |
Cząsteczki wiążące swoiste dla ASCT2 i ich zastosowanie
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
AU2017230091B2
(en)
|
2016-03-10 |
2022-04-07 |
Acceleron Pharma Inc. |
Activin type 2 receptor binding proteins and uses thereof
|
KR101783907B1
(ko)
*
|
2016-03-15 |
2017-10-10 |
다이노나(주) |
CD66c에 대한 항체와 화학치료제를 포함하는 폐암 예방 또는 치료용 약학조성물
|
EP4035711A1
(de)
|
2016-03-15 |
2022-08-03 |
Amgen Inc. |
Verringerung der wahrscheinlichkeit auf glasbruch in arzneimittelabgabevorrichtungen
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
US10988284B2
(en)
|
2016-05-13 |
2021-04-27 |
Amgen Inc. |
Vial sleeve assembly
|
EP3458988B1
(de)
|
2016-05-16 |
2023-10-18 |
Amgen Inc. |
Datenverschlüsselung in medizinischen vorrichtungen mit eingeschränkter rechenfähigkeit
|
CA3025377A1
(en)
|
2016-06-02 |
2017-12-07 |
Abbvie Inc. |
Glucocorticoid receptor agonist and immunoconjugates thereof
|
EP3465124A1
(de)
|
2016-06-03 |
2019-04-10 |
Amgen Inc. |
Wirkungstestvorrichtungen und verfahren für wirkstofffreisetzungsvorrichtungen
|
EP3478342A1
(de)
|
2016-07-01 |
2019-05-08 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit minimiertem teilebruchrisiko nach aufprallereignissen
|
US20190328965A1
(en)
|
2016-08-17 |
2019-10-31 |
Amgen Inc. |
Drug delivery device with placement detection
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
CN110662770A
(zh)
|
2016-11-23 |
2020-01-07 |
比奥维拉迪维治疗股份有限公司 |
结合凝血因子ix和凝血因子x的双特异性抗体
|
WO2018129029A1
(en)
|
2017-01-04 |
2018-07-12 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
AU2018210301A1
(en)
|
2017-01-17 |
2019-08-01 |
Amgen Inc. |
Injection devices and related methods of use and assembly
|
MX2019009625A
(es)
|
2017-02-17 |
2019-10-09 |
Amgen Inc |
Dispositivo de administracion de farmacos con trayectoria de flujo de fluido esteril y metodo relacionado de ensamblaje.
|
US11369736B2
(en)
|
2017-02-17 |
2022-06-28 |
Amgen Inc. |
Cannula insertion and retraction mechanisms
|
WO2018165143A1
(en)
|
2017-03-06 |
2018-09-13 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
EP3592402A1
(de)
|
2017-03-07 |
2020-01-15 |
Amgen Inc. |
Nadeleinführung durch überdruck
|
MX2019010671A
(es)
|
2017-03-09 |
2019-10-21 |
Amgen Inc |
Mecanismo de insercion para dispositivo de administracion de farmacos.
|
BR112019020053B1
(pt)
|
2017-03-28 |
2023-10-10 |
Amgen Inc |
Máquina para acoplar uma haste de êmbolo a um conjunto de seringa e método de utilização da referida máquina
|
US11904143B2
(en)
|
2017-06-08 |
2024-02-20 |
Amgen Inc. |
Torque driven drug delivery device
|
AU2018280054B2
(en)
|
2017-06-08 |
2023-07-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
CA3063920A1
(en)
|
2017-06-22 |
2018-12-27 |
Amgen Inc. |
Device activation impact/shock reduction
|
US11395880B2
(en)
|
2017-06-23 |
2022-07-26 |
Amgen Inc. |
Electronic drug delivery device
|
MA49562A
(fr)
|
2017-07-14 |
2020-05-20 |
Amgen Inc |
Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion
|
EP3655063A1
(de)
|
2017-07-21 |
2020-05-27 |
Amgen Inc. |
Gasdurchlässiges dichtelement für arzneimittelbehälter und verfahren zur montage
|
EP4085942A1
(de)
|
2017-07-25 |
2022-11-09 |
Amgen Inc. |
Arzneimittelabgabevorrichtung mit getriebemodul und verwandtes verfahren zur montage
|
US11484648B2
(en)
|
2017-07-25 |
2022-11-01 |
Amgen Inc. |
Drug delivery device with container access system and related method of assembly
|
MA49838A
(fr)
|
2017-08-09 |
2020-06-17 |
Amgen Inc |
Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
|
EP3668567A1
(de)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Am körper tragbarer injektor mit sterilem klebepflaster
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
MA50611A
(fr)
|
2017-10-04 |
2020-08-12 |
Amgen Inc |
Adaptateur d'écoulement destiné à un dispositif d'administration de médicament
|
WO2019070552A1
(en)
|
2017-10-06 |
2019-04-11 |
Amgen Inc. |
DRUG DELIVERY DEVICE COMPRISING A LOCKOUT ASSEMBLY AND ASSOCIATED ASSEMBLY METHOD
|
US11464903B2
(en)
|
2017-10-09 |
2022-10-11 |
Amgen Inc. |
Drug delivery device with drive assembly and related method of assembly
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
EP3703778A1
(de)
|
2017-11-03 |
2020-09-09 |
Amgen Inc. |
System und ansätze zum sterilisieren einer arzneimittelabgabevorrichtung
|
US20200338271A1
(en)
|
2017-11-06 |
2020-10-29 |
Amgen Inc. |
Fill-finish assemblies and related methods
|
CA3079197A1
(en)
|
2017-11-06 |
2019-05-09 |
Amgen Inc. |
Drug delivery device with placement and flow sensing
|
CN116832271A
(zh)
|
2017-11-10 |
2023-10-03 |
安进公司 |
用于药物递送装置的柱塞
|
CN111263651B
(zh)
|
2017-11-16 |
2022-06-17 |
安进公司 |
具有停顿和终点检测的自动注射器
|
MX2020004996A
(es)
|
2017-11-16 |
2020-08-27 |
Amgen Inc |
Un mecanismo de pestillo de puerta para un dispositivo de administracion de farmacos.
|
WO2019160976A1
(en)
|
2018-02-14 |
2019-08-22 |
Viela Bio, Inc. |
Antibodies to feline mcdonough sarcoma (fms)-like tyrosine kinase 3 receptor ligand (flt3l) and uses thereof for treating autoimmune and inflammatory diseases
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
MA53379A
(fr)
|
2018-07-24 |
2021-06-02 |
Amgen Inc |
Dispositifs d'administration pour l'administration de médicaments
|
WO2020023451A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Delivery devices for administering drugs
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
US20210260279A1
(en)
|
2018-07-24 |
2021-08-26 |
Amgen Inc. |
Hybrid drug delivery devices with optional grip portion and related method of preparation
|
US20210228797A1
(en)
|
2018-07-31 |
2021-07-29 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
AU2019347710A1
(en)
|
2018-09-24 |
2021-02-04 |
Amgen Inc. |
Interventional dosing systems and methods
|
CA3110371A1
(en)
|
2018-09-28 |
2020-04-02 |
Amgen Inc. |
Muscle wire escapement activation assembly for a drug delivery device
|
MA53815A
(fr)
|
2018-10-02 |
2022-01-05 |
Amgen Inc |
Systèmes d'injection pour administration de médicament avec transmission de force interne
|
US20210338936A1
(en)
|
2018-10-05 |
2021-11-04 |
Amgen Inc. |
Drug delivery device having dose indicator
|
TW202031306A
(zh)
|
2018-10-15 |
2020-09-01 |
美商安進公司 |
用於藥物遞送裝置之平台組裝方法
|
US20200114082A1
(en)
|
2018-10-15 |
2020-04-16 |
Amgen Inc. |
Drug delivery device having damping mechanism
|
TW202029980A
(zh)
|
2018-10-26 |
2020-08-16 |
美商免疫遺傳股份有限公司 |
E p C A M 抗體、可活化抗體及免疫偶聯物以及其用途
|
WO2020091981A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
WO2020091956A1
(en)
|
2018-11-01 |
2020-05-07 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
JP7463366B2
(ja)
|
2018-11-20 |
2024-04-08 |
タケダ ワクチン,インコーポレイテッド |
新規の抗ジカウイルス抗体及びその使用
|
JP7246409B2
(ja)
*
|
2018-12-03 |
2023-03-27 |
帝人ファーマ株式会社 |
抗igf-i受容体ヒト化抗体
|
AU2020263289A1
(en)
|
2019-04-24 |
2021-09-16 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
US20220273887A1
(en)
|
2019-08-23 |
2022-09-01 |
Amgen Inc. |
Drug delivery device with configurable needle shield engagement components and related methods
|
CR20230146A
(es)
|
2020-09-11 |
2023-06-07 |
Medimmune Ltd |
Moléculas de unión a b7-h4 terapéuticas
|
AU2021342349A1
(en)
|
2020-09-12 |
2023-05-25 |
Medimmune Limited |
A scoring method for an anti-b7h4 antibody-drug conjugate therapy
|
TW202246339A
(zh)
*
|
2021-03-03 |
2022-12-01 |
愛爾蘭商赫萊森治療愛爾蘭公司 |
治療甲狀腺眼疾的方法
|
JP2024516769A
(ja)
|
2021-03-18 |
2024-04-17 |
メドイミューン・リミテッド |
治療用結合分子
|
EP4337689A1
(de)
|
2021-05-12 |
2024-03-20 |
Applied Biomedical Science Institute |
Bindungspolypeptide gegen sars cov-2 und verwendungen davon
|
EP4341161A1
(de)
|
2021-05-21 |
2024-03-27 |
Amgen Inc. |
Verfahren zur optimierung eines füllrezepts für einen arzneimittelbehälter
|
US11807685B2
(en)
|
2021-08-05 |
2023-11-07 |
The Uab Research Foundation |
Anti-CD47 antibody and uses thereof
|
US20230107901A1
(en)
*
|
2021-10-01 |
2023-04-06 |
University Of Utah Research Foundation |
Pathologic tdp-43 as a biomarker for the diagnosis of tdp-43 proteinopathy
|
TW202348252A
(zh)
|
2022-02-16 |
2023-12-16 |
英商梅迪繆思有限公司 |
用治療性結合分子治療癌症的組合療法
|
IT202200003758A1
(it)
*
|
2022-03-01 |
2023-09-01 |
Irccs Ospedale Policlinico San Martino |
Coniugati farmacologici nella terapia del cancro.
|
WO2024015830A1
(en)
|
2022-07-12 |
2024-01-18 |
Cytomx Therapeutics, Inc. |
Epcam immunoconjugates and uses thereof
|